ENTA  valuation analysis

Basics
Name: Enanta Pharmaceuticals, Inc
Description: Enanta Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs for the treatment of viral infections and liver diseases. (more)
Industry: Biotechnology
Last 10Q10Qs are quarterly reports which contain a company's financial figures. We use these to calculate the FFER.: Feb 08, 2021
Market cap: $1.00B (1118th)
Sales(TTM): $101.65M (1249th)
Earnings(TTM): -$57.94M (1040th)

Value
FFER: 1.07 (why)
Actual price: $49.84
FFEThis is Enanta Pharmaceuticals, Inc's the estimated price. FFEs are the denominator of the FFER ratio.: $50.35
Quantile: ENTA is priced correctly given its fundamentals.
Prices as of EOD 2021-03-04
Price & Estimates
Sales & Earnings history (TTM)
Notable
  • Enanta Pharmaceuticals, Inc's earnings decreased from $33.81M to -$57.94M in the last year.
  • Enanta Pharmaceuticals, Inc's operating income decreased from $21.75M to -$66.81M in the last year.
Earnings / MarketCap
Enanta Pharmaceuticals, Inc
"Biotechnology" industry
Sales / MarketCap
Enanta Pharmaceuticals, Inc
"Biotechnology" industry
Book / MarketCap
Enanta Pharmaceuticals, Inc
"Biotechnology" industry
Equity / Assets
Enanta Pharmaceuticals, Inc
"Biotechnology" industry